Genprex (GNPX) Capital Expenditures (2016 - 2021)

Genprex (GNPX) has 6 years of Capital Expenditures data on record, last reported at $11220.0 in Q4 2021.

  • For Q4 2021, Capital Expenditures rose 269.69% year-over-year to $11220.0; the TTM value through Sep 2022 reached $11220.0, down 52.29%, while the annual FY2021 figure was $31700.0, 80.48% up from the prior year.
  • Capital Expenditures reached $11220.0 in Q4 2021 per GNPX's latest filing, down from $11338.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $91701.0 in Q1 2021 and bottomed at -$82559.0 in Q2 2021.
  • Average Capital Expenditures over 5 years is $4805.8, with a median of $3138.0 recorded in 2017.
  • Peak YoY movement for Capital Expenditures: surged 9657.8% in 2018, then plummeted 6215.48% in 2021.
  • A 5-year view of Capital Expenditures shows it stood at -$109.0 in 2017, then soared by 9657.8% to $10418.0 in 2018, then crashed by 60.54% to $4111.0 in 2019, then decreased by 26.17% to $3035.0 in 2020, then surged by 269.69% to $11220.0 in 2021.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were $11220.0 in Q4 2021, $11338.0 in Q3 2021, and -$82559.0 in Q2 2021.